[en] Objective: To evaluate the role of GnRH agonist (GnRH-a) and/or drainage in the management of large endometriomas.
DESIGN:
This prospective clinical study was conducted in a parallel and randomized design.
SETTING:
Department of Gynecology, Cliniques Universitaires St. Luc, Brussels, Belgium.
PATIENTS:
Eight infertile women with laparoscopically confirmed ovarian endometriotic cysts. After laparoscopic drainage of the ovarian cyst, patients were randomized. Patients in group I (n = 40) received no therapy. Patients in group II (n = 40) received GnRH-a therapy for 12 weeks. A second-look laparoscopy was performed after 12 weeks in each woman.
RESULTS:
After drainage, a quick recurrence of the endometrial cyst was observed in only group I. Indeed, the score and the cyst size were similar to the values observed before the first laparoscopy. In group II, a significant decrease in score and cyst diameter was observed. Ovarian biopsies revealed significant reduction in the stromal vascularization and a significant reduction in the mitotic activity in the group of women treated with GnRH-a.
CONCLUSION:
The quick recurrence of the ovarian cyst after drainage proved that drainage alone is ineffective. Drainage followed by GnRH-a was effective in the reduction of cyst size and the glandular mitotic activity.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
Donnez, Jacques
NISOLLE, Michelle ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique CHR
Gillerot, Stéphane
Anaf, Vincent
Casanas-Roux, Françoise
Clerckx, Françoise
Language :
English
Title :
Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage.
D.R. Meldrum R.J. Chang J. Lu W. Vale J. Rivier H.L. Judd Medical oophorectomy using a long-acting GnRH agonist—a possible new approach to the treatment of endometriosis J Clin Endocrinol Metab 54 1982 1081 1085
R.W. Shaw H.M. Fraser H. Boyle Intranasal treatment with luteinizing hormone-releasing hormone agonist in women with endometriosis Br Med J 287 1983 1667 1671
A. Lemay R. Maheux N. Faure C. Jean A.T.A. Fazekas Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (buserelin) as a new therapeutic approach for endometriosis Fertil Steril 41 1984 863 871
J. Donnez M. Nisolle F. Casanas-Roux Endometriosis-associated infertility: evaluation of preoperative use of danazol, gestrinone and buserelin Int J Fertil 35 1990 297 301
J. Donnez M. Nisolle-Pochet F. Clerckx-Braun J. Sandow F. Casanas-Roux Administration of nasal buserelin as compared with subcutaneous buserelin implant for endometriosis Fertil Steril 52 1989 27 30
The American Fertility Society Revised classification of endometriosis: 1985 Fertil Steril 43 1985 351 354
J. Donnez M. Nisolle Y. Karaman M. Wayembergh D. Bourgonjon F. Clerckx CO2 laser laparoscopy in peritoneal and ovarian endometrial cyst J Gynecol Surg 5 1989 361 366
V.C. Buttram Jr. R.C. Reiter S. Ward Treatment of endometriosis with danazol: report of a 6-year prospective study Fertil Steril 43 1985 353 357
M. Nisolle B. Paindaveine A. Bourdon M. Berlière F. Casanas-Roux J. Donnez Histologic study of peritoneal endometriosis in infertile women Fertil Steril 53 1990 984 988
J. Donnez M. Nisolle F. Casanas-Roux Three-dimensional architectures of peritoneal endometriosis Fertil Steril 57 1992 980 983
M. Nisolle-Pochet F. Casanas-Roux J. Donnez Histologie study of ovarian endometriosis after hormonal therapy Fertil Steril 49 1988 423 426
M. Nisolle F. Casanas-Roux V. Anaf J.-M. Mine J. Donnez Morphometric study of the stromal vascularization in peritoneal endometriosis Fertil Steril 59 1993 681 684
